Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of heat-treated zoster vaccine in autologous hematopoietic cell transplant recipients
2006-003652-37Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of heat treated zoster vaccine in herpes zoster (HZ) (2 arms), sponsored by Merck & Co. Primary endpoint: Incidence of herpes zoster. Started Oct 2006; status: completed.
02
Drugs
heat treated zoster vaccine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2006-003652-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003652-37.